NEI Research News

Researchers have stopped patient enrollment and treatment in a study designed to evaluate the safety and effectiveness of a new drug to treat a blinding eye infection common in people with AIDS.

Follow-up results from a study of premature babies with a potentially blinding condition confirm that a freezing treatment applied to their eyes helps save their sight.

A combination of two antiviral drugs is more effective than either drug alone for controlling recurrences of a blinding eye infection common in people with AIDS, according to new clinical trial results from a federally-sponsored study.

Laser therapy is a safe and effective alternative to eyedrops as afirst-line treatment for patients with newly diagnosed primaryopen-angle glaucoma, according to research results released today.

A clinical trial has found that vitrectomy, a surgical procedure to replace the gel-like filling inside the eye, need not be performed on approximately three-fourths of patients who develop a bacterial infection.

A National Eye Institute-supported clinical trial reported today that surgery for a potentially blinding condition was ineffective and may be harmful to a person’s vision.

A National Eye Institute (NEI) clinical trial reported today that anew, drug-releasing device was effective in treating cytomegalovirus (CMV) retinitis, a sight-threatening disease that affects one out of four people with AIDS.

After a decade of patient followup, a National Eye Institute (NEI)-supported study reported today that radial keratotomy (RK) remained a reasonably safe and effective technique to improve distance vision.

Over half of all people with first-time optic neuritis, a vision-impairing inflammation of the optic nerve, will eventually develop multiple sclerosis (MS).

Most adults with blinding retinitis pigmentosa (RP) should take a daily, 15,000 IU vitamin A supplement, based on results from a large, randomized clinical trial published today in the Archives of Ophthalmology.